Search results
Results from the WOW.Com Content Network
The 1998–1999 Malaysia Nipah virus outbreak occurred from September 1998 to May 1999 in the states of Perak, Negeri Sembilan and Selangor in Malaysia. A total of 265 cases of acute encephalitis with 105 deaths caused by the virus were reported in the three states throughout the outbreak. [ 1 ]
Nipah virus outbreaks have been reported in Malaysia, Singapore, Bangladesh and India. The area is known as the Nipah Belt. The highest mortality due to Nipah virus infection was found in Bangladesh, [citation needed] where outbreaks are typically seen in winter. [24] Nipah virus was first seen in 1998 in
The Nipah virus structural model, constructed at an atomic resolution, depicts a particle with a diameter of 90 nm, adorned with spikes. This model affords a glimpse into the virus's interior. The Nipah virus is known for its high mortality rate and is viewed as a potential candidate for the next pandemic.
1998–1999 Malaysia Nipah virus outbreak: 1998–1999 Malaysia: Nipah virus infection: 105 [228] 1998–2000 Democratic Republic of the Congo Marburg virus outbreak 1998–2000 Democratic Republic of the Congo: Marburg virus: 128 [229] 2000 Central America dengue epidemic 2000 Central America: Dengue fever: 40+ [230] 2001 Nigeria cholera ...
In its sixth outbreak in the country since 2001 this year, the virus, known for its 70% mortality rate, has claimed two lives out of the six who were infected in a span of few days in September ...
Nipah virus: Malaysia 1998 West Nile virus: US 1999 Itaya virus [50] Peru 1999 Rift Valley fever: Saudi Arabia and Yemen 2000 EBLV-2: Scotland 2002 SARS-CoV: 2002 Influenza A virus subtype H7N2: 2002 Monkeypox: US 2003 Chapare virus: Bolivia 2003 Plague: Algeria 2003 HTLV-3, HTLV-4: Cameroon 2005 Melaka virus: Malaysia 2006 LuJo virus: southern ...
In February 2019, US$31 million was given to the University of Tokyo, to develop a vaccine by inserting the Nipah-virus G gene ("Malaysia strain"), into a measles vector ("Edmonston B strain"). [ 5 ] In August 2019, US$43.6 million was given to Public Health Vaccines LLC, to fund the development and manufacture of a vaccine using a recombinant ...
The nine new countries set to receive the vaccine, developed by British drugmaker GSK, are Benin, Burkina Faso, Burundi, Cameroon, the Democratic Republic of the Congo, Liberia, Niger, Sierra ...